Inspire Medical Systems, Inc. Aktie News

NEW YORK, NY / ACCESSWIRE / February 16, 2024 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-lawsuit-submission-form?prid=67280&wire=1 or contact Joseph E. Levi, Esq.

If you suffered losses exceeding $100,000 investing in Inspire Medical stock or options between May 3, 2023 and November 7, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/INSP.

NEW YORK, NY / ACCESSWIRE / February 16, 2024 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-lawsuit-submission-form?prid=67276&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESSWIRE / February 15, 2024 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-lawsuit-submission-form?prid=67221&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESSWIRE / February 15, 2024 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-lawsuit-submission-form?prid=67192&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK , Feb. 15, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. ("Inspire Medical" or the "Company") (NYSE: INSP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

LOS ANGELES , Feb. 15, 2024 /PRNewswire/ --  Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Inspire Medical Systems, Inc. ("Inspire Medical" or the "Company") (NYSE: INSP). Class Period: May 3, 2023 – November 7, 2023 Lead Plaintiff Deadline: February 20, 2024 If you wish to serve as...

NEW YORK, NY / ACCESSWIRE / February 15, 2024 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-lawsuit-submission-form?prid=67162&wire=1 or contact Joseph E. Levi, Esq.